Thermo Fisher Scientific Inc. (XETRA: TN8.DE) Stock Competitors & Peer Comparison
See TN8.DE's competitors and their performance on the XETRA and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TN8.DE and its XETRA peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TN8.DE | €597.40 | -2.19% | 220.9B | 33.36 | €17.91 | +0.27% |
| DAP.DE | €202.80 | -2.87% | 142.6B | 36.63 | €5.54 | +0.66% |
| ILU.DE | €124.28 | +0.60% | 18.8B | 29.38 | €4.23 | N/A |
| QIA.DE | €45.05 | +0.26% | 9.3B | 22.01 | €2.05 | +5.36% |
| SYAB.DE | €11.06 | -0.18% | 2.4B | 27.65 | €0.40 | +2.98% |
| MYD.DE | €26.72 | +0.00% | 2.2B | -256.92 | -€0.10 | N/A |
| NN6.DE | €1.60 | -2.74% | 22.2M | -10.67 | -€0.15 | N/A |
| ECX.DE | €0.70 | -11.17% | 612.6K | -0.04 | -€19.55 | N/A |
Stock Comparison
Danaher Corporation (XETRA: DAP.DE)
TN8.DE vs DAP.DE Comparison October 2026
Thermo Fisher Scientific Inc. (XETRA: TN8.DE) plays a significant role within the Healthcare sector. Its performance on the XETRA reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TN8.DE stands at 220.9B. In comparison, DAP.DE has a market cap of 142.6B. Regarding current trading prices, TN8.DE is priced at €597.40 on the XETRA, while DAP.DE trades at €202.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TN8.DE currently has a P/E ratio of 33.36, whereas DAP.DE's P/E ratio is 36.63. In terms of profitability, TN8.DE's ROE is +0.13%, compared to DAP.DE's ROE of +0.08%. Regarding short-term risk, TN8.DE is less volatile compared to DAP.DE. This indicates lower risk in terms of short-term price fluctuations for TN8.DE.Check DAP.DE's competition here